Loxapine update: 1966-1976.
D000208:Acute Disease; D000284:Administration, Oral; D000367:Age Factors; D000553:Ambulatory Care; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002908:Chronic Disease; D003342:Corpus Striatum / Q000187:drug effects; D003989:Dibenzoxazepines / Q000627:therapeutic use*; D004347:Drug Interactions; D006760:Hospitalization; D006801:Humans; D008134:Long-Term Care; D008152:Loxapine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011954:Receptors, Dopamine / Q000187:drug effects; D012107:Research Design; D012559:Schizophrenia / Q000188:drug therapy*; D012737:Sex Factors
D000978:Antiparkinson Agents; D003989:Dibenzoxazepines; D011954:Receptors, Dopamine; D008152:Loxapine